Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Airbnb
ABNB
|
$1.37B |
| 2 |
DocuSign
DOCU
|
$884M |
| 3 |
Eli Lilly
LLY
|
$797M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$748M |
| 5 |
CrowdStrike
CRWD
|
$727M |
Top Sells
| 1 |
Peloton Interactive
PTON
|
$1.3B |
| 2 |
RingCentral
RNG
|
$885M |
| 3 |
Apple
AAPL
|
$855M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
$751M |
| 5 |
Trade Desk
TTD
|
$577M |
Sector Composition
| 1 | Technology | 34.7% |
| 2 | Consumer Discretionary | 21.76% |
| 3 | Communication Services | 16.85% |
| 4 | Financials | 8.56% |
| 5 | Healthcare | 7.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Bio-Rad Laboratories Class A
BIO
$8B
| $18.9M | 0.01% |
29,260
+7,402
| +34% | +$4.77M |
|
377
Coupang
CPNG
$52.7B
| $18.8M | 0.01% |
+450,522
| New | +$18.8M |
|
378
C4 Therapeutics
CCCC
$194M
| $18.5M | 0.01% |
488,175
-2,973
| -0.6% | -$113K |
|
379
Veracyte
VCYT
$2.55B
| $18.4M | 0.01% |
460,445
-278,449
| -38% | -$11.1M |
|
|
CVET
380
DELISTED
Covetrus, Inc. Common Stock
CVET
| $18.4M | 0.01% |
679,612
-19,776
| -3% | -$534K |
|
|
AXNX
381
DELISTED
Axonics, Inc. Common Stock
AXNX
| $18.3M | 0.01% |
+288,324
| New | +$18.3M |
|
382
BHP
BHP
$138B
| $18.1M | 0.01% |
278,546
-42,378
| -13% | -$2.75M |
|
383
Howard Hughes
HHH
$4.69B
| $18M | 0.01% |
193,575
+56,877
| +42% | +$5.28M |
|
384
Qiagen
QGEN
$10.3B
| $17.7M | 0.01% |
+345,695
| New | +$17.7M |
|
385
MGM Resorts International
MGM
$9.98B
| $17.7M | 0.01% |
414,634
+401,499
| +3,057% | +$17.1M |
|
386
Ralph Lauren
RL
$18.9B
| $17.6M | 0.01% |
149,754
+65,964
| +79% | +$7.77M |
|
387
Oric Pharmaceuticals
ORIC
$1.06B
| $17.6M | 0.01% |
996,945
-146,534
| -13% | -$2.59M |
|
388
ProQR Therapeutics
PRQR
$258M
| $17.5M | 0.01% |
2,600,427
| – | – |
|
389
Treace Medical Concepts
TMCI
$453M
| $17.5M | 0.01% |
+560,652
| New | +$17.5M |
|
390
Insulet
PODD
$24.5B
| $17.4M | 0.01% |
63,536
-191,044
| -75% | -$52.4M |
|
391
Constellium
CSTM
$2.04B
| $17.3M | 0.01% |
912,076
+201,526
| +28% | +$3.82M |
|
392
Mayville Engineering Co
MEC
$302M
| $17.2M | 0.01% |
855,211
-26,603
| -3% | -$535K |
|
393
HealthEquity
HQY
$7.88B
| $17M | 0.01% |
210,898
-5,273
| -2% | -$424K |
|
394
Payoneer
PAYO
$2.4B
| $16.8M | 0.01% |
+1,647,381
| New | +$16.8M |
|
|
MMP
395
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $16.6M | 0.01% |
339,106
+82,568
| +32% | +$4.04M |
|
396
Agilon Health
AGL
$497M
| $16.6M | 0.01% |
+408,643
| New | +$16.6M |
|
397
Toll Brothers
TOL
$14.2B
| $16.5M | 0.01% |
286,233
+189,706
| +197% | +$11M |
|
398
Roku
ROKU
$14B
| $16.5M | 0.01% |
+36,027
| New | +$16.5M |
|
|
UMH
399
UMH Properties
UMH
$1.29B
| $16.5M | 0.01% |
756,121
+625,072
| +477% | +$13.6M |
|
400
Repligen
RGEN
$7.01B
| $16.5M | 0.01% |
82,634
-110,359
| -57% | -$22M |
|